Not sure when it was updated, but the presentation section of OCC now includes an OrthoATI presentation.
Pretty good information for those investors not completely familiar with some of the successes of OCC therein, and its potential:
https://www.orthocell.com.au/new-page-2
Again, the company gave everyone a pretty obvious heads up on the Striate deal in its October 2021 presentation, on a possible deal, that was remarkeably like the one they announced just this month. One could be forgiven for make similar assumptions from this presentation too:
Technology transfer to the US? Now where, or with whom could they possibly partner with in this I wonder?
Ann: OrthoATI Tendon Clinical Study Success, page-212
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.8¢ |
Change
0.008(1.97%) |
Mkt cap ! $81.63M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 38.8¢ | $4.669K | 11.98K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 70290 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 25000 | 2 |
View Market Depth
| Last trade - 15.21pm 31/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |